The Third Affiliated Hospital Third Military Medical University; PLA
发明人:
申请号：
EP15857765.0
公开号：
EP3216447A4
申请日:
2015.11.05
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention belongs to pharmaceutical field, specifically, relates to use of Edaravone in the preparation of a medicament for preventing and treating cerebral amyloid angiopathy (CAA). By administering Edaravone, the present invention could scavenge the deposited amyloid (A²) in the brain and prevent the intracerebral A² deposition.
